Breakthrough Surgical Sealant Designed to Help Reduce

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
93
Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Colorectal Surgery

Cohera Medical, Inc.® Enrolls First Patient in Clinical Trial of its Sylys® Surgical Sealant in the U.S.

RALEIGH, N.C., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, today announced that it has enrolled the first patient in a prospective, multicenter, randomized clinical trial for its Sylys® Surgical Sealant device. 

Sylys® Surgical Sealant is intended to be used as an adjunct to standard closure techniques for the reinforcement and protection of anastomotic junctions in colorectal and ileorectal anastomosis procedures.  Sylys is a resorbable synthetic sealant designed to help reduce anastomotic leakage by providing additional support to the anastomosis during the first few days of healing, when the development of leaks is most likely to occur.

The randomized clinical study will compare patients undergoing colorectal and ileorectal anastomosis after resection with and without the sealant.  The study is the first phase of a clinical trial program designed to support the safety and efficacy of the sealant in reducing the leak rate in these procedures.

Anastomotic leakage, which occurs in up to 23 percent of patients undergoing colorectal surgery, is considered to be one of the most serious surgical complications encountered, frequently resulting in the rapid development of severe peritonitis, septic shock, multiple organ dysfunction, and death. At least one third of post-surgical deaths following colorectal surgery are attributed to leaks, and survivors generally have protracted and expensive recoveries.

“The start of our U.S. clinical trial for Sylys® Surgical Sealant is another major milestone for Cohera,” said Patrick Daly, President and CEO of Cohera Medical, Inc®.  “The hard work and dedication of the entire team and our clinical partners is paying dividends now and we believe will provide patient and surgeon benefits in the future with reduced leaks and co-morbidities.”   

The market for Sylys® Surgical Sealant is significant, with more than one million procedures per year worldwide representing a multi-billion dollar opportunity. Due to the unmet clinical need, Sylys would represent a breakthrough in this market that will lead to improved patient outcomes as well as reduced patient management costs for healthcare providers.

About Cohera Medical

Cohera Medical, Inc. is a growing medical device company that is developing and commercializing a line of surgical adhesives and sealants. Cohera Medical’s products are based on a unique chemical design that is resorbable, non-toxic, and easy-to-use. The Company’s lead product, TissuGlu Surgical Adhesive, is indicated for use in the U.S. for the approximation of tissue planes in abdominoplasty procedures. Refer to the complete Directions for Use information available at TissuGlu.com for a full description of use information including the contraindications, warnings, precautions, benefits, and risks of use of TissuGlu Surgical Adhesive. TissuGlu is currently approved for sale in the EU for the approximation of tissue layers where subcutaneous dead space exists between the tissue planes in large flap surgical procedures such as abdominoplasty and is being utilized in Europe to eliminate drains or reduce complications in patients undergoing large flap surgical procedures such as abdominoplasty, mastectomy, ventral hernia repair, decubitus and latissimus dorsi flap procedures. The Company’s second product under development, Sylys® Surgical Sealant, the first synthetic sealant designed specifically to help reduce anastomotic leaks, has received CE Mark approval in Europe as an adjunct to standard closure in ileostomy reversal procedures. TissuGlu and Sylys are the first products in a pipeline of technology that includes adhesives for surgical mesh fixation, meniscal repair and other orthopedic indications. Sylys and the other Cohera Medical products are currently available for investigational use only and have not yet been approved for sale by the Food and Drug Administration (FDA) in the U.S..

Certain statements made throughout this press release that are not historical facts contain forward-looking statements regarding the Company’s future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements.

©2016 Cohera Medical, Inc. All Rights Reserved. Cohera Medical, Inc.®, TissuGlu® and Sylys® are registered trademarks of Cohera Medical, Inc. TissuGlu® Surgical Adhesive is covered by one or more of the following U.S. Patents 7,264,823; 8,182,647; 8,652,293; 8,950,629. Other Patents Pending.

MEDIA CONTACTS Cohera Medical, Inc. Lindsay Koren Sr. Marketing Manager lkoren@coheramed.com (984) 222-0400 (office) MedThink Communications Alison Puzia Senior Account Executive apuzia@medthink.com (919) 926-3628 (office)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 43

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading
Bizzdesign Tops Gartner’s 2026 Enterprise Architecture List

Updated Category News Views 49

Enterprise Architecture’s Silent Backbone Sometimes it's the quiet operators like Bizzdesign that hijack the spotlight after years of steady steering. With the latest nod from Gartner, Bizzdesign is clearly on a tear in the enterprise architecture domain. In their 2026 Critical Capabilities report, Bizzdesign's products—Horizzon, Alfabet, and Hopex—secured top spots...

Continue Reading
Fortvita's Zybrivo Gains CHMP Nod: A European Leap

Updated Category News Views 87

It's not every day you're reading about a biotech making a ground-breaking shift off Chinese shores, but Fortvita's latest breakthrough is worth noting. Their fancy immunotherapy, Zybrivo® (sintilimab), just snagged a nod from the CHMP, Europe's committee that guides many on the medicinal merry-go-round. This isn't just your run-of-the-mill nod either. We're talking...

Continue Reading
Mining Equipment Market to Surge, Hitting $42.81B by 2033

Updated Category News Views 12

Forecasts on Market Growth: A Robust Climb Ahead Brace yourself because this mining equipment racket is ramping up like you wouldn't believe. Analysts are telling us the market's supposed to roar from a $28.42 billion check in 2026 to a jaw-dropping $42.81 billion come 2033. That's a 6.0% CAGR—a figure that'll catch the eye of anyone not sound asleep at the wheel....

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 34

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading
MoneyGram and Solflare Boost Crypto Cash-Out Options

Updated Category News Views 55

Crypto Meets Cash: A New Partnership in Money Movement Here's something to chew over your morning joe: MoneyGram's stepping up its game in the crypto world. They're pairing up with Solflare to let folks convert their USDC into hard cash across 170 countries and territories—no fees until New Year's Eve. It's like crypto's getting a passport to the physical world and not...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 53

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 54

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
KuCoin Unveils $1.1M USDT Black Friday Bonanza

Updated Category News Views 31

KuCoin's Festive Fireworks: Black Friday Bonanza Sometimes the crypto world feels like a carnival, and KuCoin's latest act is the $1.1 million USDT prize pool, rolling out as part of its 'Tis The Season holiday campaign. A move that matches the glitz of Tomorrowland Winter experiences, adding more sparkle to the crypto stage. Behind the Scenes of the KuCoin-Tomorrowland...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Challenge: Investors Pursue Justice Against TLX

Updated Category News Views 164

Opportunity for Investors in Telix Pharmaceuticals Ltd. Attention, investors! A significant event has unfolded for those who have purchased securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). The Rosen Law Firm, well-known for representing investors' rights, has initiated a class action lawsuit on behalf of these investors. This development presents a chance for you...

Continue Reading
Turvo and SMC3 Forge Alliance to Enhance Freight Efficiency

Updated Category News Views 158

Strategic Partnership Between Turvo and SMC3 Industry leaders are joining forces to enhance freight management solutions, facilitated by insights from a global logistics company. Turvo, known for its collaborative application tailored for the supply chain, has announced an integration partnership with SMC3, a respected provider of less-than-truckload (LTL) freight...

Continue Reading
Fnac Darty Takes Major Steps in Unieuro Acquisition Process

Updated Category News Views 148

Fnac Darty Makes Progress in Unieuro Acquisition Fnac Darty has recently announced significant developments regarding its acquisition of Unieuro. The authorization to officially notify this transaction was granted by the European Commission, following a pre-notification phase that lasted several months. This is an exciting development for shareholders and has set the...

Continue Reading
LOGISTEC Appoints Cleidy Liborio Fernandes as CCO for Growth

Updated Category News Views 202

CLEIDY LIBORIO FERNANDES JOINS LOGISTEC AS CHIEF COMMERCIAL OFFICER LOGISTEC, a prominent provider of marine and environmental services in North America, is delighted to announce the appointment of Cleidy Liborio Fernandes as the new Chief Commercial Officer. Cleidy's extensive background in international business and strategic development is expected to spearhead the...

Continue Reading
IMUNON Inc's Latest Developments Drive Stock Surge Today

Updated Category News Views 233

IMUNON Inc's Stock Surge Explained Shares of IMUNON Inc (NASDAQ: IMNN) are seeing a remarkable uptick in trading this Wednesday. The excitement is largely due to the company achieving a significant clinical milestone for its lead drug candidate, IMNN-001. This news has generated substantial interest among investors and highlights IMUNON's progress in the pharmaceutical...

Continue Reading